Clinical trial
CLarifying ABCB1's Role in Amyloid Efflux and Alzheimer's Disease Risk
NCT07393113 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CLarifying ABCB1's Role in Amyloid Efflux and Alzheimer's Disease Risk
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 25, 2023
- Completion date
- December 31, 2025
- Enrollment
- 510 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.